News
17h
Zacks.com on MSNHere's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock NowAstellas Pharma (ALPMY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could ...
For the Nifty 50 index, any dips are likely to be bought into as long as the index remains above 24,350. On the higher end, ...
After reaching an all-time low of $0.67 in April, KAITO has surged over 200%, crossing $2. A golden cross between the 20 EMA ...
The short-term uptrend remains intact for the Nifty-50 index, which is expected to show bounce back from near the crucial supports of around 24500-24400 levels in the next few sessions. Immediate ...
XRP price action on lower timeframes, specifically under the 4-hour mark, remains notably uncertain, with erratic fluctuations and a lack of clear directional bias. However, a deeper analysis reveals ...
XRP has gained significant momentum over the past several days, posting a sharp 24% rally since last week as bullish sentiment returns to the broader crypto market. With Bitcoin holding above $100K ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results